drugset / Trial / NCT00005920

Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

NCT00005920

Phase 2 Terminated 70 enrolled Merck Sharp & Dohme LLC
Parallel-groupTreatment

Summary

The purpose of this study is to see if it is safe and effective to give L-743,872 to patients with thrush, an AIDS-related yeast infection of the mouth, that has not been cured with fluconazole treatment.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Caspofungin Other / unclassified Intravenous